JP Morgan Chase’s Pliant Therapeutics PLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Sell
861,823
-351,052
-29% -$443K ﹤0.01% 4608
2025
Q4
$1.48M Sell
1,212,875
-917,614
-43% -$1.38M ﹤0.01% 4334
2025
Q3
$3.15M Buy
2,130,489
+172,056
+9% +$263K ﹤0.01% 3741
2025
Q2
$2.27M Buy
1,958,433
+1,477,336
+307% +$2.09M ﹤0.01% 3815
2025
Q1
$649K Buy
481,097
+283,846
+144% +$1.72M ﹤0.01% 4619
2024
Q4
$2.6M Buy
197,251
+148,039
+301% +$2.02M ﹤0.01% 3945
2024
Q3
$552K Buy
49,212
+22
+0% +$275 ﹤0.01% 4833
2024
Q2
$529K Sell
49,190
-9,138
-16% -$118K ﹤0.01% 4663
2024
Q1
$869K Sell
58,328
-27,265
-32% -$450K ﹤0.01% 4447
2023
Q4
$1.55M Buy
85,593
+3,747
+5% +$57K ﹤0.01% 4022
2023
Q3
$1.42M Buy
81,846
+8,649
+12% +$150K ﹤0.01% 3819
2023
Q2
$1.33M Buy
73,197
+51,970
+245% +$1.23M ﹤0.01% 3839
2023
Q1
$565K Buy
21,227
+6,268
+42% +$178K ﹤0.01% 4420
2022
Q4
$290K Sell
14,959
-22,012
-60% -$460K ﹤0.01% 4842
2022
Q3
$772K Buy
36,971
+35,385
+2,231% +$677K ﹤0.01% 4192
2022
Q2
$13K Sell
1,586
-14,169
-90% -$90.7K ﹤0.01% 5988
2022
Q1
$110K Sell
15,755
-38,081
-71% -$389K ﹤0.01% 5462
2021
Q4
$727K Buy
53,836
+37,268
+225% +$592K ﹤0.01% 4602
2021
Q3
$280K Buy
16,568
+3,448
+26% +$73.2K ﹤0.01% 5056
2021
Q2
$382K Sell
13,120
-16,570
-56% -$516K ﹤0.01% 4863
2021
Q1
$1.17M Buy
29,690
+25,014
+535% +$812K ﹤0.01% 4108
2020
Q4
$106K Buy
4,676
+793
+20% +$19.9K ﹤0.01% 4987
2020
Q3
$92K Buy
+3,883
New +$97K ﹤0.01% 4731

Other funds holding PLRX